Pigmented Purpuric Dermatoses

1036 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

The pigmented purpuric dermatoses form a group of chronic skin diseases with a characteristic appearance. The aetiology is unknown but they tend to affect the lower limb and there is extravasation of erythrocytes in the skin with marked deposition of haemosiderin[1].

There are a number of clinical patterns but all with a similar histological appearance. Generally, the treatment and prognosis are similar. The pigmented purpuric dermatoses include[2]:

  • Schamberg's disease (progressive pigmentary dermatosis).
  • Eczematoid-like purpura of Doucas and Kapetanakis.
  • Majocchi's disease (purpura annularis telangiectodes).
  • Pigmented purpuric lichenoid dermatosis of Gougerot and Blum.
  • Lichen aureus.
  • Itching purpura.
Pigmented Purpuric Dermatosis

Many consider itching purpura and eczematoid-like purpura to be variants of Schamberg's disease.

The aetiology is unknown but important contributory factors include venous hypertension, exercise and gravitational dependency[2]. Histology shows a perivascular lymphocytic infiltrate of T cells centred on the superficial small blood vessels of the skin, suggesting that cell-mediated immunity plays a part[3]. There is swelling of endothelial cells and narrowing of the lumen. Extravasation of red blood cells occurs with marked deposition of haemosiderin in macrophages, and a rare granulomatous variant of chronic pigmented dermatosis has been reported.

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »

The conditions are uncommon. Generally they affect males more than females, except in Majocchi's disease. There is no racial difference in incidence.

  • Schamberg's disease occurs at any age.
  • Itching purpura and the dermatosis of Gougerot and Blum typically affect middle-aged men.
  • Majocchi's disease occurs mostly in children or in young adults.
  • Lichen aureus occurs mostly in young adults but rare cases affecting children have been reported[4].

Both Schamberg's disease and Majocchi's disease have rarely been reported in families, suggesting a genetic aetiology or predisposition. It may be autosomal dominant[5].

Some forms of the pigmented purpuric dermatoses are associated with the ingestion of drugs, including non-steroidal anti-inflammatory agents, sedatives, antihypertensives, drugs with antihistaminic properties and lipid-lowering agents[6]. Cases associated with sildenafil and isotretinoin have been reported[7][8]. Lichen aureus may be associated with trauma.

Schamberg's disease

  • Schamberg's disease is the most common form of pigmented purpura and is the most common cause of petechiae in children. It is most commonly seen in the late teens and early 20s, although it has been diagnosed in children aged between 1 and 9 years[9]. It is more common in males than in females, although a report of children included three boys and ten girls.

See see separate Schamberg's disease article for further details.

Eczematoid-like purpura of Doucas and Kapetanakis

  • This disorder is similar to Schamberg's disease but occurs predominantly in adult males.
  • The lesions, which may be itchy, commonly begin on the lower legs and progress to the thighs, trunk and upper limbs.
  • It is a chronic relapsing disorder which may remit spontaneously.
  • Lichenification may also be present due to chronic scratching of the pruritic lesions.

Majocchi's disease (purpura annularis telangiectodes)

  • Majocchi's disease typically presents with annular erythematous plaques and patches which have central areas of atrophy, commonly in a symmetrical distribution on the lower limbs but occasionally on the trunk and upper limbs.
  • Girls are more often affected than boys, most often in adolescence or early adulthood.
  • Despite a chronic relapsing course which lasts several years, the disorder is benign and self-limiting and treatment is neither effective nor required.
  • It is associated with haematological conditions and rarely T-cell cutaneous lymphoma[10].

Pigmented purpuric lichenoid dermatosis of Gougerot and Blum

This condition is extremely similar to Majocchi's disease but presents in adults (usually men) and is not seen in children.

Lichen aureus

  • Lichen aureus, as its name suggests, presents with yellowish or red papules or patches which may either itch or be asymptomatic.
  • The lesions frequently occur bilaterally on the lower limbs, although can be unilateral and may affect the trunk and upper limbs[11].
  • Unlike the other forms of pigmented purpuric eruptions, the lesions of lichen aureus may also occur in a dermatomal distribution, or can follow the distribution of veins or arteries.
  • It is thought that it may sometimes be associated with trauma but it does not appear to be associated with the ingestion of drugs.
  • Once again, although the lesions may be cleared using oral corticosteroids, the risks of treatment outweigh the benefits, as it follows a benign course.

Despite the distinctive appearance of the lesions, several other conditions must be considered as a differential diagnosis, including:

  • There is no specific investigation to diagnose the disorder.
  • Routine laboratory investigations, such as FBC, clotting studies and ESR, show no abnormality although they may be performed to exclude other disease.
  • There are no established guidelines for investigation of patients with pigmented purpuric lesions. Where skin biopsies are performed, histology will reveal evidence of capillaritis of the upper dermal vessels, extravasation of the red blood cells with haemosiderin deposits in the macrophages and an essentially normal epidermis. Biopsy may be helpful to exclude an early T-cell lymphoma.

Non-drug

  • Avoid prolonged dependency of the legs.
  • If there is venous stasis, compression may be beneficial.
  • In view of the appearance and the chronic nature of the disorder, both children and their parents will require reassurance as to the benign nature of the disorder.
  • Adolescents and young adults may benefit from counselling because of the unsightly nature of the lesions.
  • Schamberg's disease, pigmented purpuric lichenoid dermatosis of Gougerot and Blum and lichen aureus may benefit from treatment with psoralen combined with ultraviolet A (PUVA)[12][13][14].
  • One study has reported the use of advanced fluorescence technology (a method of delivering an intense beam of fluorescent light) in Schamberg's disease of the legs, with favourable results[15].
  • Difficult or persistent cases of pigmented purpuric eruption may benefit from narrowband UVB therapy[16]. Successful use in children with Schamberg's disease has been reported[15].

Drugs

  • The pigmented purpuric dermatoses follow a benign but chronic course. Although treatment with oral steroids can be effective in clearing the lesions, these are not generally used, as the risks of treatment far outweigh any potential benefits.
  • Antihistamines may offer relief from pruritus but at the cost of sedation.
  • Topical steroid creams may bring some symptomatic relief.
  • Aminaphtone has been found to be helpful in Schamberg's disease (not licensed in the UK).
  • Pentoxifylline has also been found to be beneficial (also unlicensed use)[3].
  • Treatments tried for lichen aureus include topical pimecrolimus 1% cream and a combination of pentoxifylline and epoprostenol (prostacyclin)[17].
  • All forms of pigmented purpuric dermatoses have a chronic, relapsing and remitting benign course and are not associated with any other physical abnormality.
  • Spontaneous remissions may occur.
  • Very rare descriptions have occurred of T-cell lymphoma occurring in patients with a diagnosis of Schamberg's disease[18].

Further reading & references

  1. Sardana K, Sarkar R, Sehgal VN; Pigmented purpuric dermatoses: an overview; Int J Dermatol. 2004 Jul;43(7):482-8.
  2. Sharma L, Gupta S; Clinicoepidemiological study of pigmented purpuric dermatoses. Indian Dermatol Online J. 2012 Jan;3(1):17-20. doi: 10.4103/2229-5178.93486.
  3. Mun JH, Jwa SW, Song M, et al; Extensive pigmented purpuric dermatosis successfully treated with pentoxifylline. Ann Dermatol. 2012 Aug;24(3):363-5. doi: 10.5021/ad.2012.24.3.363. Epub 2012 Jul 25.
  4. Kim MJ, Kim BY, Park KC, et al; A case of childhood lichen aureus. Ann Dermatol. 2009 Nov;21(4):393-5. Epub 2009 Nov 30.
  5. Sethuraman G, Sugandhan S, Bansal A, et al; Familial pigmented purpuric dermatoses. J Dermatol. 2006 Sep;33(9):639-41.
  6. Magro CM, Schaefer JT, Crowson AN, et al; Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles. Am J Clin Pathol. 2007 Aug;128(2):218-29.
  7. Kocak AY, Akay BN, Heper AO; Sildenafil-induced pigmented purpuric dermatosis. Cutan Ocul Toxicol. 2013 Mar;32(1):91-2. doi: 10.3109/15569527.2012.702838. Epub 2012 Jul 11.
  8. Kaplan R, Meehan SA, Leger M; A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis. JAMA Dermatol. 2014 Feb;150(2):182-4. doi: 10.1001/jamadermatol.2013.7371.
  9. Torrelo A, Requena C, Mediero IG, et al; Schamberg's purpura in children: a review of 13 cases. J Am Acad Dermatol. 2003 Jan;48(1):31-3.
  10. Miller K, Fischer M, Kamino H, et al; Purpura annularis telangiectoides. Dermatol Online J. 2012 Dec 15;18(12):5.
  11. Fink-Puches R, Wolf P, Kerl H, et al; Lichen aureus: clinicopathologic features, natural history, and relationship to mycosis fungoides. Arch Dermatol. 2008 Sep;144(9):1169-73. doi: 10.1001/archderm.144.9.1169.
  12. Lichen aureuse; Scholarship, University of California
  13. Seckin D, Yazici Z, Senol A, et al; A case of Schamberg's disease responding dramatically to PUVA treatment. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):95-6.
  14. Kocaturk E, Kavala M, Zindanci I, et al; Narrowband UVB treatment of pigmented purpuric lichenoid dermatitis (Gougerot-Blum). Photodermatol Photoimmunol Photomed. 2009 Feb;25(1):55-6.
  15. Manolakos DA, Weiss J, Glick B, et al; Treatment of Schamberg's disease with advanced fluorescence technology. J Drugs Dermatol. 2012 Apr;11(4):528-9.
  16. Fathy H, Abdelgaber S; Treatment of pigmented purpuric dermatoses with narrow-band UVB: a report of six cases. J Eur Acad Dermatol Venereol. 2011 May;25(5):603-6. doi: 10.1111/j.1468-3083.2010.03806.x.
  17. Cather JC; Asymptomatic golden macule on the ankle. Proc (Bayl Univ Med Cent). 2008 Jan;21(1):73-4.
  18. Shen A et al; Capillaritis as a potential harbinger of cutaneous T-cell lymphoma, Dermatology Clinic Online, 2004

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Laurence Knott
Current Version:
Peer Reviewer:
Prof Cathy Jackson
Document ID:
2611 (v24)
Last Checked:
11/08/2016
Next Review:
10/08/2021

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

 
 
Patient Access app - find out more Patient facebook page - Like our page